slow responders to glp 1 Understanding GLP-1 in Weight Management Slow Responders Unite! GIVE. IT.
Description
For patients with type 2 diabetes, a 26-week phase II trial showed that 48% of participants achieved at least 10% weight reduction after treatment with orforglipron 45 mg
Participants frequently reported stigma associated with using weight-loss medications
4 Discussion In 2019, an oral form of semaglutide was approved for treatment of diabetes, and subsequently obesity, namely, Rybelsus
PLoS One 8 , e61965 (2013)
